Your Article Summary
See Latest ArticlesMelatonin as a potential therapeutic agent in psychiatric illness
Human Psychopharmacology: Clinical and Experimental, 07/01/09
Maldonado MD et al. - The pathogenesis of mental disorders remains ambiguous and neuroinflammation has been proposed as a causative agent. This study considers the potential contributions of melatonin as therapeutic agent in CNS and during neuroinflammation in mental disorders.
Related Articles
Coping Strategies of Hospitalized People with Psychiatric Disabilities in Taiwan
Psychiatric Quarterly, 10/21/09
Relevance Score: 67%
Training in partnership: role of service users with intellectual disability and carers
Psychiatric Bulletin, 11/16/09
Relevance Score: 64%
Parole Revocation Among Prison Inmates With Psychiatric and Substance Use Disorders
Psychiatric Services, 11/05/09
Relevance Score: 64%
Impact of psychiatric and social characteristics on HIV sexual risk behavior in Puerto Rican women with severe mental illness
Social Psychiatry and Psychiatric Epidemiology, 10/30/09
Relevance Score: 64%
The relationship of multiple aspects of stigma and personal contact with someone hospitalized for mental illness, in a nationally representative sample
Social Psychiatry and Psychiatric Epidemiology, 10/20/09
Relevance Score: 64%
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of Tuberculin Skin Testing Reactivity in Opioid-Dependent Patients Seeking Treatment with Methadone versus Buprenorphine: Policy Implications for Tuberculosis Screening
American Journal of Drug & Alcohol Abuse, 12/17/09
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man
World Journal of Biological Psychiatry, 12/17/09
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
World Journal of Biological Psychiatry, 12/17/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of Tuberculin Skin Testing Reactivity in Opioid-Dependent Patients Seeking Treatment with Methadone versus Buprenorphine: Policy Implications for Tuberculosis Screening
American Journal of Drug & Alcohol Abuse, 12/17/09
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man
World Journal of Biological Psychiatry, 12/17/09
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
World Journal of Biological Psychiatry, 12/17/09